Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Antibiotics and Intravitreous Injections
NCT00410891Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jul 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gatifloxacin in bacterial infection, sponsored by Stanford University. Primary endpoint: Positive Culture at Day 1. Started Jul 2008; status: completed.
02
Drugs
gatifloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00410891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410891.